These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33509069)

  • 1. Inflammation in Alzheimer's Disease.
    Fakhoury M
    Curr Alzheimer Res; 2020; 17(11):959-961. PubMed ID: 33509069
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease.
    Ozben T; Ozben S
    Clin Biochem; 2019 Oct; 72():87-89. PubMed ID: 30954437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-cholinergic pharmacotherapy approaches to Alzheimer's disease: the use of non-steroidal anti-inflammatory drugs.
    Tsartsalis S; Panagopoulos PK; Mironidou-Tzouveleki M
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):133-9. PubMed ID: 20874697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets.
    Caraci F; Copani A; Nicoletti F; Drago F
    Eur J Pharmacol; 2010 Jan; 626(1):64-71. PubMed ID: 19837057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease.
    Perrin RJ; Fagan AM; Holtzman DM
    Nature; 2009 Oct; 461(7266):916-22. PubMed ID: 19829371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches.
    Singh RK
    Curr Neuropharmacol; 2020; 18(9):868-882. PubMed ID: 31989900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.
    Jiang Q; Heneka M; Landreth GE
    CNS Drugs; 2008; 22(1):1-14. PubMed ID: 18072811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for Alzheimer's disease.
    Dinsmore ST
    J Am Osteopath Assoc; 1999 Sep; 99(9 Suppl):S6-8. PubMed ID: 10730506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAID and Alzheimer's disease; possible answers and new questions.
    Davis KL
    Mol Psychiatry; 2002; 7(9):925-6. PubMed ID: 12399941
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptomatic therapeutic aspects in Alzheimer's disease.
    Gauthier S
    Handb Clin Neurol; 2008; 89():269-71. PubMed ID: 18631751
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Alzheimer's disease. The status quo].
    Diehl J; Kurz A
    Med Monatsschr Pharm; 2002 Jan; 25(1):8-12. PubMed ID: 11826666
    [No Abstract]   [Full Text] [Related]  

  • 12. Statin therapy in Alzheimer's disease.
    Kivipelto M; Solomon A; Winblad B
    Lancet Neurol; 2005 Sep; 4(9):521-2. PubMed ID: 16109358
    [No Abstract]   [Full Text] [Related]  

  • 13. Anesthetics and its impact on the brain and Alzheimer's disease.
    Mandal PK; Ritchie K; Fodale V
    J Alzheimers Dis; 2014; 39(2):223-5. PubMed ID: 24150107
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammatory mechanisms in Alzheimer's disease: implications for therapy.
    Aisen PS; Davis KL
    Am J Psychiatry; 1994 Aug; 151(8):1105-13. PubMed ID: 7518651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: pathophysiology and the hope for therapy.
    Brumback RA; Leech RW
    J Okla State Med Assoc; 1994 Mar; 87(3):103-11. PubMed ID: 8195921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: is there a problem beyond recognition?
    Fowler CJ; O'Neill C; Garlind A; Cowburn RF
    Trends Pharmacol Sci; 1990 May; 11(5):183-4. PubMed ID: 2188400
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's unease.
    Hensrud DD
    Fortune; 2002 Oct; 146(8):226. PubMed ID: 12407786
    [No Abstract]   [Full Text] [Related]  

  • 18. Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease.
    Maczurek A; Shanmugam K; Münch G
    Ann N Y Acad Sci; 2008 Apr; 1126():147-51. PubMed ID: 18448809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydroaminoacridine in Alzheimer's disease.
    Walsh AC
    BMJ; 1989 Jun; 298(6687):1579. PubMed ID: 2503129
    [No Abstract]   [Full Text] [Related]  

  • 20. The overlap between epilepsy and Alzheimer's disease and the consequences for treatment.
    Powell G; Ziso B; Larner AJ
    Expert Rev Neurother; 2019 Jul; 19(7):653-661. PubMed ID: 31238746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.